Program Annual Meeting 2024
Thursday, August 1, 2024
7:30 AM – 8:30 AM
Industry Sponsored Session 1
8:30 AM – 8:45 AM
Break
8:45 AM – 9:00 AM
Opening Remarks, Presidential & Program Chair Welcome
9:00 AM – 10:15 AM
General Session 1
10:15 AM – 10:45 AM
Break
10:45 AM – 12:15 PM
Oral Abstract Session 1
10:45 AM – 11:00 AM
A Novel Multi-Strain Vaginal Synbiotic Is Effective in Optimizing the Vaginal Microbiome: Results From a Randomized, Placebo-Controlled Clinical Trial (#001)
Speaker:
Jacques Ravel, Phd (Institute for Genome Sciences; Department of Microbiology and Immunology, University of Maryland, School of Medicine)
11:00 AM – 11:15 AM
Vaginal Odor Is Associated With Increased Abundance of Prevotella, Megasphaera, Porphyromonas, and Finegoldia (#002)
Speaker:
Krystal Thomas-White (Evvy)
11:15 AM – 11:30 AM
Comparison of Endocervical Immune Cell Populations, Vaginal Microbiota and Mucosal Immune Response in Women Treated With Rituximab and Untreated Controls (#003)
Speaker:
Ofri Bar (Massachusetts General Hospital and The Hebrew University of Jerusalem)
11:30 AM – 11:45 AM
Modulation of Mucosal Glycans by the Vaginal Microbiome: A Risk Factor for Chlamydia Infection? (#004)
Speaker:
Katherine Heger (University of Calgary)
11:45 AM – 12:00 PM
Investigating Pathogenesis of Sneathia Species Using a Human 3D Cervical Model (#005)
Speaker:
Paweł łaniewski (University of Arizona College of Medicine – Phoenix)
12:00 PM – 12:15 PM
The Impact of Gender-Affirming Testosterone Therapy on the Vaginal Microbiota of Transgender Men and Non-binary People Assigned Female Sex at Birth (#006)
Speaker:
Olivia Van Gerwen (University of Alabama at Birmingham)
12:30 PM – 1:30 PM
Industry Sponsored Session 2
1:30 PM – 2:30 PM
Oral Abstract Session 2
1:30 PM – 1:45 PM
National Perspectives of Youth: Evaluating Adolescents’ Attitudes Towards Self-Swabbing for Home-Based STI Testing (#007)
Speaker:
Theresa Rager (University of Michigan Medical School)
1:45 PM – 2:00 PM
Associations Between Relationship Dynamics and STI Expedited Partner Therapy Acceptance and Delivery Among Adolescent Girls and Young Women in Johannesburg, South Africa (#008)
Speaker:
Rebecca Howett (University of Washington)
2:00 PM – 2:15 PM
Nitazoxanide and Tizoxanide Demonstrate High Levels of in Vitro Activity Against Metronidazole-Susceptible and Metronidazole-Resistant Trichomonas Vaginalis Clinical Isolates (#009)
Speaker:
Keonte Graves (Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham)
2:15 PM – 2:30 PM
Testing for Gonorrhea and Chlamydia Among People With Opioid Use Disorder During Pregnancy (#010)
Speaker:
K. Meryl Davis (CDC Foundation)
2:30 PM – 3:15 PM
Stump the Professors
3:30 PM – 4:30 PM
Poster Session 1
Home-Based STI Test Kits: Barriers to Use Among a Nationwide Cohort of Adolescents and Young Adults (#029)
Speaker:
Katie Foug (University of Michigan Medical School)
Economic Evaluation of a Nucleic Acid Amplification Test Panel for Diagnosis of Bacterial Vaginosis, Vulvovaginal Candidiasis, Trichomoniasis, and Mixed Infections Among Patients With Vaginitis Symptoms in the United States (US) (#030)
Speaker:
Kai-Erh Kao (Broadstreet HEOR)
Role of Intercellular Adhesion Molecule 1 (ICAM-1) in Group B Streptococcus-Induced Host Immune Response (#031)
Speaker:
Natalie Smith (University of Tennessee-Knoxville)
The Impact of Maternal Influenza Vaccination on Influenza Disease Severity During Pregnancy and Postpartum in Rural Nepal (#032)
Speaker:
Collrane Frivold (University of Washington, Departments of Medicine and Epidemiology)
Longitudinal Analysis of Select Bacterial Species Composition Among Women With Incident Bacterial Vaginosis Illuminated Through PNA-FISH (#033)
Speaker:
Sheridan George (University of Alabama at Birmingham)
Prevalence of Common Sexually Transmitted Infections and Human Papillomavirus in Normal and Abnormal Cervical Cytology Specimens (#034)
Speaker:
Joshua Kostera (Abbott Laboratories)
Predicting STI Positivity in U.S. Cisgender Women Using Electronic Resources (#035)
Speaker:
Lillee Izadi (Johns Hopkins School of Medicine, Department of Gynecology and Obstetrics)
Group B Streptococcus (GBS) Colonization and Risk for Preterm Delivery in High-Risk Pregnancies With Cervical Cerclage (#036)
Speaker:
Monica Sosa (Department of Obstetrics & Gynecology, University of Washington)
Rsv Vaccination Rates Among Eligible Pregnant Patients After Abrysvo Availability: Provider Counseling and Patient Acceptance (#037)
Speaker:
Jennifer Cate (Duke University)
RSV Vaccination Rates Among Eligible Patients After Abrysvo Availability: Patient Factors (#038)
Speaker:
Jennifer Cate (Duke University)
Nursing Perceptions of Barriers to Infection Prevention and Control in Labor and Delivery (#039)
Speaker:
Kiran M Perkins (Centers for Disease Control and Preventions)
Effect of Sexually Transmitted Infections on Vaginal and Serum Cytokine Concentration (#040)
Speaker:
Marisa R. Young (Department of Gynecology and Obsteterics, Emory University School of Medicine)
Peripartum Retention in Care for People With HIV: Where Can We Intervene? (#041)
Speaker:
Alexandra Latham (Baylor College of Medicine)
Estimated Cytomegalovirus Seroprevalence in Europe by Age and Sex (#042)
Speaker:
John Diaz-Decaro (Moderna, Inc.)
COVID Vaccine Uptake Among Pregnant Individuals With and Without HIV (#043)
Speaker:
Jordyn Hurly (Johns Hopkins University School of Medicine)
Pharmacokinetic and Safety Results From Two Phase 1 Studies of Oteseconazole in Women With Severe Renal Insufficiency Not Requiring Dialysis vs Normal Renal Function and Women With Moderate Hepatic Impairment vs Normal Hepatic Function (#044)
Speaker:
Stephen Brand (Mycovia Pharmaceuticals, Inc.)
Assessment of Obstetrician Knowledge and Aptitude for the Treatment of Hepatitis C in the Postpartum Period Prior to Protocol Implementation (#045)
Speaker:
Erik Holder (University of Texas Health Science Center at San Antonio)
Investigating Microbial Dynamics and Bacterial Vaginosis Susceptibility in Women Who Have Sex With Women (#046)
Speaker:
Darianne Zimmer (University of California, Riverside School of Medicine)
Hepatitis C in Appalachia: A Cohort Study of Obstetric Data From a Regional Academic Medical Center (#047)
Speaker:
Rebecca Purvis (University of Tennessee Graduate School of Medicine)
Placental Pathologic Findings Associated With SARS-CoV-2 Infection in Pregnancy (#048)
Speaker:
Clara Van Ommen (University of British Columbia)
Surveying Awareness of Human Papillomavirus in Nursing Staff (#049)
Speaker:
Eugenia Lee (Brigham and Women’s Hospital)
Is Preterm Delivery Associated With Higher Likelihood of Systemic Infection in Patients With Post-cesarean Wound Infection? (#050)
Speaker:
Ashley Cummings (Duke University School of Medicine)
Association Between Socioeconomic Status and Maternal Risk Factors on the Likelihood and Severity of Medically Attended Respiratory Syncytial Virus–Lower Respiratory Tract Illness (#051)
Speaker:
Sarah Pugh (Pfizer, Inc.)
Examining Racial and Ethnic Disparities in the Incidence of Urinary Tract Infection During Pregnancy: A Cohort Study (#052)
Speaker:
Sandra Mcateer (University of Washington)
Disparities in COVID-19 Vaccine Uptake Among Pregnant People in a Diverse Urban Population With High Vaccine Acceptance (#053)
Speaker:
Christine A. Blauvelt (University of California, San Francisco)
Improving Peri-Operative Antibiotic Management at the Time of Cesarean Delivery to Reduce Surgical Site Infections (SSI) in Women With Severe Postpartum Hemorrhage at a Single Institution (#054)
Speaker:
Bryce Beyer (University of Tennessee Medical Center)
4:30 PM – 5:00 PM
Break
5:00 PM – 6:30 PM
Welcome Reception
Friday, August 2, 2024
7:30 AM – 8:30 AM
Industry Sponsored Session 3
8:30 AM – 9:30 AM
General Session 2
9:30 AM – 10:30 AM
Oral Abstract Session 3
9:30 AM – 9:45 AM
First-Trimester Antibiotic Treatments for Urinary Tract Infections and Risk of Congenital Malformations (#011)
Speaker:
Yanmin Zhu (Brigham and Women’s Hospital and Harvard Medical School)
9:45 AM – 10:00 AM
Placental Malaria Induces a Unique Placental Methylation Profile Associated With Fetal Growth Restriction (#012)
Speaker:
Nida Ozarslan (UCSF)
10:00 AM – 10:15 AM
Outcomes of Hepatitis B and Hepatitis Delta Co-infection in Hospitalized Pregnant Women in the United States: A Nationwide Study (#013)
Speaker:
Paul Wasuwanich (University of Florida College of Medicine)
10:15 AM – 10:30 AM
Doubling Down: Characteristics and Outcomes Associated With Discretionary Dosing of Penicillin Among People With Early Syphilis During Pregnancy (#014)
Speaker:
K. Meryl Davis (CDC Foundation)
10:30 AM – 11:00 AM
Break
11:00 AM – 12:15 PM
Oral Abstract Session 4
11:00 AM – 11:15 AM
Antepartum Versus Postpartum Amoxicillin Oral Challenge in Penicillin-Allergic Pregnant Patients: A Two-Center Prospective Cohort Study (#015)
Speaker:
Jeffrey Man Hay Wong (University of British Columbia)
11:15 AM – 11:30 AM
Risk-Stratified Management to Remove Low-Risk Penicillin Allergy Labels During the Postpartum Hospitalization (#016)
Speaker:
Ann Tucker (Vanderbilt University Medical Center)
11:30 AM – 11:45 AM
A Retrospective Analysis of Obstetric Outcomes After the Implementation of Standardized Perinatal Sepsis Order Set (#017)
Speaker:
Nathalie Chang (University of Texas Health Science Center San Antonio)
11:45 AM – 12:00 PM
Clinical and Social Factors Influencing Respiratory Syncytial Virus (RSV) Vaccine Uptake in Pregnancy (#018)
Speaker:
Bolu Idowu (Vanderbilt University Medical Center)
12:00 PM – 12:15 PM
Uptake of the Respiratory Syncytial Virus (RSV) Vaccine and Nirsevimab Among Pregnant Patients and Their Neonates (#019)
Speaker:
Christine A. Blauvelt (University of California, San Francisco)
12:30 PM – 1:30 PM
Industry Sponsored Session 4
1:30 PM – 2:30 PM
Poster Session 2
A Novel Multi-Strain Vaginal Synbiotic Is Effective in Inhibiting Microbes Associated With Vaginal Dysbiosis, Inflammation, and Mucus Barrier Degradation (#055)
Speaker:
Jacques Ravel, Phd (Institute for Genome Sciences; Department of Microbiology and Immunology, University of Maryland, School of Medicine)
The Relationship Between Transportation Insecurity and Influenza Vaccination Among Pregnant Individuals in the US: An Opportunity for a Bundled Intervention (#056)
Speaker:
Jodian Pinkney (Massachusetts General Hospital)
Immunometabolic Impacts of Phthalates on the Urogenital Microenvironment of Reproductive Aged Women: A Pilot Study (#057)
Speaker:
Holly Chatenoud (University of Arizona College of Medicine – Phoenix, Phoenix, AZ and University of Bath, Bath, UK)
Technology for Sexual Health Equity: Reaching Vulnerable Communities in Maryland With Free, Self-Collected Sexually Transmitted Infection Testing (#058)
Speaker:
Camille Shantz (Johns Hopkins School of Medicine)
Unlocking Insights to Improve Sexual Healthcare Access: Demographics Associated With Maryland Youth Completing Free, Self-Collected Sexually Transmitted Infection Testing (#059)
Speaker:
Camille Shantz (Johns Hopkins School of Medicine)
Three-Year Efficacy of a Multidisciplinary Approach to Penicillin Allergy Delabelling in Pregnant Patients (#060)
Speaker:
Jeffrey Man Hay Wong (University of British Columbia)
Understanding Interactions Between Lactobacillus Spp and Group B Streptococcus in the Vaginal Tract (#061)
Speaker:
Jéssica Da Conceiçao Mendonça (University of Tennessee)
Development of a Novel Model to Study the Impact of Zinc on Group B Streptococcal Vaginal Cell Interactions (#062)
Speaker:
Abbey Behler (University of Tennessee)
Predictors of Congenital Syphilis From a Regional Health System in Louisiana (#063)
Speaker:
Mariella Gastanaduy (Ochsner Health System)
Investigating the Impact of a Prior COVID-19 Infection on the Vaginal Microenvironment (#064)
Speaker:
Hannah Harris (University of Arizona, College of Medicine-Phoenix)
Do Rates of Surgical Site Infections After Cesarean Delivery Change After Implementation of an Enhanced Recovery After Cesarean Program? (#065)
Speaker:
Seoyon Lee (University of Texas Health Science Center at San Antonio)
Exploring Vaginal Microbiome and Quality of Life Variations in Benign Gynecologic Conditions (#066)
Speaker:
Nicole Jimenez (Universiyt of Arizona- College of Medicine-Phoenix)
Incidence of and Risk Factors for Surgical Management in the Setting of Post-cesarean Wound Infection (#067)
Speaker:
Janice Wong (Duke University)
Real-World Clinical Burden of Vaginitis Symptoms in the United States (US) (#068)
Speaker:
Rebecca Lillis (LSU Health Sciences Center)
Hansen’s Disease in Pregnancy: A Scoping Review (#069)
Speaker:
Jeffrey Man Hay Wong (University of British Columbia)
Characteristics of Individuals Who Developed Chorioamnionitis After Cerclage Placement During Pregnancy (#070)
Speaker:
Rjika Weis Lottes (University of Washington School of Medicine)
Evaluating the Prevalence of Long COVID in Patients Exposed to SARS-COV2 During Pregnancy (#071)
Speaker:
Ilona Goldfarb (Department of Obstetrics and Gynecology, Massachusetts General Hospital)
Investigating the Performance of Serum Biomarkers Used to Predict Preeclampsia in Patients With Acute Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (#072)
Speaker:
Carolynn Dude (Emory University School of Medicine, Endeavor/NorthShore Health System)
The Incidence of Peripartum Invasive Aroup a Streptococcal Infections (#073)
Speaker:
Elizabeth Wagman (Thomas Jefferson University)
Kinetics of Vaginal Microbial and Immune Responses to Antibiotic Treatment for Bacterial Vaginosis (#074)
Speaker:
Philipp Foessleitner (Vincent Center for Reproductive Biology, Massachusetts General Hospital, Harvard Medical School)
Patterns of Nontreponemal Titer (NT) Decline in Pregnant Patients With Syphilis (#075)
Speaker:
Sabrina Dacosta (UT Health Houston Science Center)
Focused Intervention for Cervical Cancer Screening Improved Screening Rates at Ryan White Funded Clinic (#076)
Speaker:
Latoya Harris (University of Kentucky)
Identifying the Role of Peroxide Stress Regulation in Vaginal Colonization of Streptococcus Agalactiae (#077)
Speaker:
Stephen Lumsdaine (University of Tennessee Knoxville)
Cost-Effectiveness of Cefazolin and Indomethacin for Exam-Indicated Cerclage (#078)
Speaker:
Osinakachukwu Mbata (Duke University School of Medicine)
Penicillin Allergy Testing in Pregnancy: Testing Results and Impact on Subsequent Antibiotic Utilization (#079)
Speaker:
Ann Tucker (Vanderbilt University Medical Center)
2:30 PM – 3:30 PM
CDC Focus Group*
7:00 PM – 11:00 PM
Awards Ceremony/Dinner Dance
Saturday, August 3, 2024
7:30 AM – 8:30 AM
Annual Business Meeting
8:30 AM – 9:45 AM
General Session 3
9:45 AM – 10:30 AM
Oral Abstract Session 5
9:45 AM – 10:00 AM
Group B Streptococcus Colonization and Chorioamnionitis Among Nulliparous Individuals in the nuMoM2B Cohort (#020)
Speaker:
Marissa Berry (The Ohio State University)
10:00 AM – 10:15 AM
Effects of Integrase Strand Transfer Inhibitors (INSTIs) Versus Non-INSTI Regimen Exposures on Pregnancy Outcomes, Maternal Weight Gain and HIV Viral Suppression (#021)
Speaker:
Fouzia Z.a.khan (Johns Hopkins University School of Medicine)
10:15 AM – 10:30 AM
Cytomegalovirus Infection During Pregnancy: Comparison Between Women Living With and Without Human Immunodeficiency Virus (#022)
Speaker:
Isabelle Boucoiran (University of Montreal)
10:30 AM – 11:00 AM
Break
11:00 AM – 12:30 PM
Oral Abstract Session 6
11:00 AM – 11:15 AM
Pilot Case Series of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (#023)
Speaker:
Kim Langdon (Coologics, Inc)
11:15 AM – 11:30 AM
A Randomized, Double-Blind, Placebo- And Active-Controlled, Parallel, Nested Crossover, QT Study of Oteseconazole in Healthy Women (#024)
Speaker:
Stephen Brand (Mycovia Pharmaceuticals, Inc.)
11:30 AM – 11:45 AM
Neighborhood Socioeconomic Disadvantage and Chorioamnionitis (#025)
Speaker:
Christine Field (The Ohio State University)
11:45 AM – 12:00 PM
Impact of the COVID-19 Pandemic on Existing Disparities in Congenital Syphilis Rates Across Los Angeles County
Speaker:
Elaine Chan (University of California, Los Angeles)
12:00 PM – 12:15 PM
Species-Specific Differences in Glycogen Utilization Associate With Lactic Acid Levels in the Vagina (#027)
Speaker:
Karen Lithgow (University of Calgary)
12:15 PM – 12:30 PM
Leveraging Machine Learning Techniques to Investigate the Pathogenesis of Incident Bacterial Vaginosis (#028)
Speaker:
Jacob Elnaggar (Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center)
12:30 PM – 12:35 PM
Wrap Up/Adjourn Meeting